肝炎的診斷及治療、肝癌的診斷及治療、肝硬化、超音波、胃食道逆流、消化道潰瘍、膽胰疾病
前高雄醫學大學,醫學系,教授
前高雄醫學大學附設醫院,肝膽胰內科,主任
前高雄醫學大學附設醫院,社區健康中心,主任
Centers for Disease Control, U.S.A.,Hepatitis Branch,Guest Researcher
University of Arkansas for Medical Sciences, U.S.A.,School of Medicine,Guest Assistant Professor
高雄醫學大學醫學研究所博士
1. Tsai JF, Perng DS.
Diabetes mellitus as a risk factor of hepatocellular carcinoma in patients with chronic hepatitis B on nucleot(s)ide analogues. J Hepatol. 2019 Apr;70(4):795-796
2. Tsai JF, Chen SC, Lin ZY, Dai CY, Huang JF, Yu ML, Chuang WL.
Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
Kaohsiung J Med Sci. 2017 Sep;33(9):453-457
3. Tsai JF, Chen SC, Lin ZY, Dai CY, Huang JF, Yu ML, Chuang WL.
Interactive effects between Lymphotoxin α +252 polymorphism and habits of substance use on risk of hepatocellular carcinoma.Kaohsiung J Med Sci. 2017 Jul;33(7):334-338.
義大醫院‧總機電話:07-615-0011‧07-952-0011 地址:82445高雄市燕巢區角宿里義大路1號
語音‧人工掛號專線:07-615-0900‧07-615-0911 週一至週五 07:30~16:30 週六 07:30~11:30
© Copyright 2014. "EDAGI" All rights reserved.